Samil Pharmaceutical Co.,Ltd (KRX:000520)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,100
+130 (1.30%)
At close: Oct 2, 2025
1.30%
Market Cap213.78B
Revenue (ttm)217.19B
Net Income (ttm)-19.82B
Shares Out21.23M
EPS (ttm)-974.90
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume96,239
Average Volume215,014
Open10,010
Previous Close9,970
Day's Range9,900 - 10,140
52-Week Range9,540 - 19,500
Beta0.35
RSI42.06
Earnings DateNov 14, 2025

About KRX:000520

Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Se... [Read more]

Sector Healthcare
Founded 1947
Employees 583
Stock Exchange Korea Stock Exchange
Ticker Symbol 000520
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.